The global Glucagon Like Peptide 1 Analogs Market is estimated to be valued at US$ 12.55 billion in 2021 and is expected to exhibit a CAGR of 6.10% over the forecast period of 2022 to 2029, according to a new report published by Coherent Market Insights.